Medco Health Solutions Inc (mhs)

[Bart Myers]

Morgan Stanley is out with its report today on Medco Health Solutions (NYSE: MHS), maintaining Overweight.

In a note to clients, Morgan Stanley writes, "Framing a bear case scenario, if MHS were to retain only 92% of its ~$17 billion in revenues up for renewal (mirroring CVS' renewal rates in the 2009/2010 season) as compared to historical 99% retention rate, we quantify an EPS impact of ~ $0.10 to $0.15 to our 2012e EPS of $5.12. Under that scenario, ESRX may stand to gain share."


Source: http://www.benzinga.com/analyst-ratings/analyst-color/11/03/932746/morgan-stanley-maintains-overweight-on-medco-health-solut#ixzz1GrsdMy2h